Summer Haven Investment Management, LLC Innoviva, Inc. Transaction History

Summer Haven Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$14.4 - $16.4 $14,112 - $16,071	980 Added 1.66%	59,853 $981,000
Q1 2024 Apr 16, 2024	BUY	$14.56 - $16.78 $8,372 - $9,648	575 Added 0.99%	58,873 $897,000
Q4 2023 Feb 05, 2024	BUY	$12.32 - $16.27 $8,685 - $11,470	705 Added 1.22%	58,298 $935,000
Q3 2023 Oct 13, 2023	BUY	$12.37 - $13.89 $152,076 - $170,763	12,294 Added 27.14%	57,593 $748,000
Q2 2023 Jul 24, 2023	SELL	$11.39 - $13.72 $112,817 - $135,896	-9,905 Reduced 17.94%	45,299 $576,000
Q1 2023 Apr 13, 2023	BUY	$10.73 - $13.6 $15,762 - $19,978	1,469 Added 2.73%	55,204 $621,000
Q4 2022 Jan 18, 2023	BUY	$11.8 - $13.78 $9,794 - $11,437	830 Added 1.57%	53,735 $0
Q3 2022 Oct 20, 2022	BUY	$11.61 - $15.22 $614,227 - $805,214	52,905 New	52,905 $614,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Summer Haven Investment Management, LLC with notifications on news.